Shopping Cart 0
Cart Subtotal
USD 0

Global Next-Generation Biologics Market Report 2019, Competitive Landscape, Trends and Opportunities

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 2960

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 3460

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 4500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 4500

Details

The Next-Generation Biologics market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Next-Generation Biologics market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Next-Generation Biologics market.

Major players in the global Next-Generation Biologics market include:

Sanofi

Eli Lilly

Kyowa Hakko Kirin

Biogen Idec

Allergan

Roche

Novo Nordisk

Bayer

Pfizer

Molecular Partners

On the basis of types, the Next-Generation Biologics market is primarily split into:

Antibodies

Regenerative medicine

Insulins

Growth hormones

Other

On the basis of applications, the market covers:

Medical

Scientific Research

Other

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:

United States

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Central and South America (Brazil, Mexico, Colombia)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Other Regions

Chapter 1 provides an overview of Next-Generation Biologics market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Next-Generation Biologics market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Next-Generation Biologics industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Next-Generation Biologics market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Next-Generation Biologics, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Next-Generation Biologics in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Next-Generation Biologics in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Next-Generation Biologics. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Next-Generation Biologics market, including the global production and revenue forecast, regional forecast. It also foresees the Next-Generation Biologics market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:

Historical Years: 2014-2018

Base Year: 2019

Estimated Year: 2019

Forecast Period: 2019-2026

READ MORE

Table Of Content

Scope

Table of Contents

1 Next-Generation Biologics Market Overview

1.1 Product Overview and Scope of Next-Generation Biologics

1.2 Next-Generation Biologics Segment by Type

1.2.1 Global Next-Generation Biologics Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Antibodies

1.2.3 The Market Profile of Regenerative medicine

1.2.4 The Market Profile of Insulins

1.2.5 The Market Profile of Growth hormones

1.2.6 The Market Profile of Other

1.3 Global Next-Generation Biologics Segment by Application

1.3.1 Next-Generation Biologics Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Medical

1.3.3 The Market Profile of Scientific Research

1.3.4 The Market Profile of Other

1.4 Global Next-Generation Biologics Market by Region (2014-2026)

1.4.1 Global Next-Generation Biologics Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3 Europe Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.1 Germany Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.2 UK Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.3 France Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.4 Italy Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.5 Spain Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.6 Russia Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.7 Poland Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.4 China Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.5 Japan Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.6 India Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.8 Central and South America Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Next-Generation Biologics Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Next-Generation Biologics (2014-2026)

1.5.1 Global Next-Generation Biologics Revenue Status and Outlook (2014-2026)

1.5.2 Global Next-Generation Biologics Production Status and Outlook (2014-2026)

2 Global Next-Generation Biologics Market Landscape by Player

2.1 Global Next-Generation Biologics Production and Share by Player (2014-2019)

2.2 Global Next-Generation Biologics Revenue and Market Share by Player (2014-2019)

2.3 Global Next-Generation Biologics Average Price by Player (2014-2019)

2.4 Next-Generation Biologics Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Next-Generation Biologics Market Competitive Situation and Trends

2.5.1 Next-Generation Biologics Market Concentration Rate

2.5.2 Next-Generation Biologics Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 Sanofi

3.1.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Next-Generation Biologics Product Profiles, Application and Specification

3.1.3 Sanofi Next-Generation Biologics Market Performance (2014-2019)

3.1.4 Sanofi Business Overview

3.2 Eli Lilly

3.2.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Next-Generation Biologics Product Profiles, Application and Specification

3.2.3 Eli Lilly Next-Generation Biologics Market Performance (2014-2019)

3.2.4 Eli Lilly Business Overview

3.3 Kyowa Hakko Kirin

3.3.1 Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Next-Generation Biologics Product Profiles, Application and Specification

3.3.3 Kyowa Hakko Kirin Next-Generation Biologics Market Performance (2014-2019)

3.3.4 Kyowa Hakko Kirin Business Overview

3.4 Biogen Idec

3.4.1 Biogen Idec Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Next-Generation Biologics Product Profiles, Application and Specification

3.4.3 Biogen Idec Next-Generation Biologics Market Performance (2014-2019)

3.4.4 Biogen Idec Business Overview

3.5 Allergan

3.5.1 Allergan Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Next-Generation Biologics Product Profiles, Application and Specification

3.5.3 Allergan Next-Generation Biologics Market Performance (2014-2019)

3.5.4 Allergan Business Overview

3.6 Roche

3.6.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Next-Generation Biologics Product Profiles, Application and Specification

3.6.3 Roche Next-Generation Biologics Market Performance (2014-2019)

3.6.4 Roche Business Overview

3.7 Novo Nordisk

3.7.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Next-Generation Biologics Product Profiles, Application and Specification

3.7.3 Novo Nordisk Next-Generation Biologics Market Performance (2014-2019)

3.7.4 Novo Nordisk Business Overview

3.8 Bayer

3.8.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Next-Generation Biologics Product Profiles, Application and Specification

3.8.3 Bayer Next-Generation Biologics Market Performance (2014-2019)

3.8.4 Bayer Business Overview

3.9 Pfizer

3.9.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Next-Generation Biologics Product Profiles, Application and Specification

3.9.3 Pfizer Next-Generation Biologics Market Performance (2014-2019)

3.9.4 Pfizer Business Overview

3.10 Molecular Partners

3.10.1 Molecular Partners Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Next-Generation Biologics Product Profiles, Application and Specification

3.10.3 Molecular Partners Next-Generation Biologics Market Performance (2014-2019)

3.10.4 Molecular Partners Business Overview

4 Global Next-Generation Biologics Production, Revenue (Value), Price Trend by Type

4.1 Global Next-Generation Biologics Production and Market Share by Type (2014-2019)

4.2 Global Next-Generation Biologics Revenue and Market Share by Type (2014-2019)

4.3 Global Next-Generation Biologics Price by Type (2014-2019)

4.4 Global Next-Generation Biologics Production Growth Rate by Type (2014-2019)

4.4.1 Global Next-Generation Biologics Production Growth Rate of Antibodies (2014-2019)

4.4.2 Global Next-Generation Biologics Production Growth Rate of Regenerative medicine (2014-2019)

4.4.3 Global Next-Generation Biologics Production Growth Rate of Insulins (2014-2019)

4.4.4 Global Next-Generation Biologics Production Growth Rate of Growth hormones (2014-2019)

4.4.5 Global Next-Generation Biologics Production Growth Rate of Other (2014-2019)

5 Global Next-Generation Biologics Market Analysis by Application

5.1 Global Next-Generation Biologics Consumption and Market Share by Application (2014-2019)

5.2 Global Next-Generation Biologics Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Next-Generation Biologics Consumption Growth Rate of Medical (2014-2019)

5.2.2 Global Next-Generation Biologics Consumption Growth Rate of Scientific Research (2014-2019)

5.2.3 Global Next-Generation Biologics Consumption Growth Rate of Other (2014-2019)

6 Global Next-Generation Biologics Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Next-Generation Biologics Consumption by Region (2014-2019)

6.2 United States Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.3 Europe Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.4 China Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.5 Japan Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.6 India Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

7 Global Next-Generation Biologics Production, Revenue (Value) by Region (2014-2019)

7.1 Global Next-Generation Biologics Production and Market Share by Region (2014-2019)

7.2 Global Next-Generation Biologics Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

8 Next-Generation Biologics Manufacturing Analysis

8.1 Next-Generation Biologics Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Next-Generation Biologics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Next-Generation Biologics Industrial Chain Analysis

9.2 Raw Materials Sources of Next-Generation Biologics Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Next-Generation Biologics

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Next-Generation Biologics Market Forecast (2019-2026)

11.1 Global Next-Generation Biologics Production, Revenue Forecast (2019-2026)

11.1.1 Global Next-Generation Biologics Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Next-Generation Biologics Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Next-Generation Biologics Price and Trend Forecast (2019-2026)

11.2 Global Next-Generation Biologics Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Next-Generation Biologics Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Next-Generation Biologics Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source


List Of Figure

List of Tables and Figures

Figure Next-Generation Biologics Product Picture

Table Global Next-Generation Biologics Production and CAGR (%) Comparison by Type

Table Profile of Antibodies

Table Profile of Regenerative medicine

Table Profile of Insulins

Table Profile of Growth hormones

Table Profile of Other

Table Next-Generation Biologics Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Medical

Table Profile of Scientific Research

Table Profile of Other

Figure Global Next-Generation Biologics Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Europe Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Germany Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure UK Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure France Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Italy Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Spain Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Russia Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Poland Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure China Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Japan Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure India Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Malaysia Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Singapore Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Philippines Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Indonesia Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Thailand Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Vietnam Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Central and South America Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Brazil Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Mexico Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Colombia Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Turkey Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Egypt Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure South Africa Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Nigeria Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Global Next-Generation Biologics Production Status and Outlook (2014-2026)

Table Global Next-Generation Biologics Production by Player (2014-2019)

Table Global Next-Generation Biologics Production Share by Player (2014-2019)

Figure Global Next-Generation Biologics Production Share by Player in 2018

Table Next-Generation Biologics Revenue by Player (2014-2019)

Table Next-Generation Biologics Revenue Market Share by Player (2014-2019)

Table Next-Generation Biologics Price by Player (2014-2019)

Table Next-Generation Biologics Manufacturing Base Distribution and Sales Area by Player

Table Next-Generation Biologics Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table Sanofi Profile

Table Sanofi Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Eli Lilly Profile

Table Eli Lilly Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Kyowa Hakko Kirin Profile

Table Kyowa Hakko Kirin Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Biogen Idec Profile

Table Biogen Idec Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Allergan Profile

Table Allergan Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Roche Profile

Table Roche Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Novo Nordisk Profile

Table Novo Nordisk Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Bayer Profile

Table Bayer Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Pfizer Profile

Table Pfizer Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Molecular Partners Profile

Table Molecular Partners Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Next-Generation Biologics Production by Type (2014-2019)

Table Global Next-Generation Biologics Production Market Share by Type (2014-2019)

Figure Global Next-Generation Biologics Production Market Share by Type in 2018

Table Global Next-Generation Biologics Revenue by Type (2014-2019)

Table Global Next-Generation Biologics Revenue Market Share by Type (2014-2019)

Figure Global Next-Generation Biologics Revenue Market Share by Type in 2018

Table Next-Generation Biologics Price by Type (2014-2019)

Figure Global Next-Generation Biologics Production Growth Rate of Antibodies (2014-2019)

Figure Global Next-Generation Biologics Production Growth Rate of Regenerative medicine (2014-2019)

Figure Global Next-Generation Biologics Production Growth Rate of Insulins (2014-2019)

Figure Global Next-Generation Biologics Production Growth Rate of Growth hormones (2014-2019)

Figure Global Next-Generation Biologics Production Growth Rate of Other (2014-2019)

Table Global Next-Generation Biologics Consumption by Application (2014-2019)

Table Global Next-Generation Biologics Consumption Market Share by Application (2014-2019)

Table Global Next-Generation Biologics Consumption of Medical (2014-2019)

Table Global Next-Generation Biologics Consumption of Scientific Research (2014-2019)

Table Global Next-Generation Biologics Consumption of Other (2014-2019)

Table Global Next-Generation Biologics Consumption by Region (2014-2019)

Table Global Next-Generation Biologics Consumption Market Share by Region (2014-2019)

Table United States Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table Europe Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table China Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table Japan Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table India Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table Central and South America Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table Global Next-Generation Biologics Production by Region (2014-2019)

Table Global Next-Generation Biologics Production Market Share by Region (2014-2019)

Figure Global Next-Generation Biologics Production Market Share by Region (2014-2019)

Figure Global Next-Generation Biologics Production Market Share by Region in 2018

Table Global Next-Generation Biologics Revenue by Region (2014-2019)

Table Global Next-Generation Biologics Revenue Market Share by Region (2014-2019)

Figure Global Next-Generation Biologics Revenue Market Share by Region (2014-2019)

Figure Global Next-Generation Biologics Revenue Market Share by Region in 2018

Table Global Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table China Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table India Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Next-Generation Biologics

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Next-Generation Biologics

Figure Next-Generation Biologics Industrial Chain Analysis

Table Raw Materials Sources of Next-Generation Biologics Major Players in 2018

Table Downstream Buyers

Figure Global Next-Generation Biologics Production and Growth Rate Forecast (2019-2026)

Figure Global Next-Generation Biologics Revenue and Growth Rate Forecast (2019-2026)

Figure Global Next-Generation Biologics Price and Trend Forecast (2019-2026)

Table United States Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table Europe Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table China Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table Japan Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table India Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table Middle East and Africa Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table Global Next-Generation Biologics Market Production Forecast, by Type

Table Global Next-Generation Biologics Production Volume Market Share Forecast, by Type

Table Global Next-Generation Biologics Market Revenue Forecast, by Type

Table Global Next-Generation Biologics Revenue Market Share Forecast, by Type

Table Global Next-Generation Biologics Price Forecast, by Type

Table Global Next-Generation Biologics Market Production Forecast, by Application

Table Global Next-Generation Biologics Production Volume Market Share Forecast, by Application

Table Global Next-Generation Biologics Market Revenue Forecast, by Application

Table Global Next-Generation Biologics Revenue Market Share Forecast, by Application

Table Global Next-Generation Biologics Price Forecast, by Application

Licence Rights

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The Next-Generation Biologics market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Next-Generation Biologics market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Next-Generation Biologics market.

Major players in the global Next-Generation Biologics market include:

Sanofi

Eli Lilly

Kyowa Hakko Kirin

Biogen Idec

Allergan

Roche

Novo Nordisk

Bayer

Pfizer

Molecular Partners

On the basis of types, the Next-Generation Biologics market is primarily split into:

Antibodies

Regenerative medicine

Insulins

Growth hormones

Other

On the basis of applications, the market covers:

Medical

Scientific Research

Other

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:

United States

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Central and South America (Brazil, Mexico, Colombia)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Other Regions

Chapter 1 provides an overview of Next-Generation Biologics market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Next-Generation Biologics market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Next-Generation Biologics industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Next-Generation Biologics market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Next-Generation Biologics, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Next-Generation Biologics in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Next-Generation Biologics in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Next-Generation Biologics. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Next-Generation Biologics market, including the global production and revenue forecast, regional forecast. It also foresees the Next-Generation Biologics market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:

Historical Years: 2014-2018

Base Year: 2019

Estimated Year: 2019

Forecast Period: 2019-2026

READ MORE

Scope

Table of Contents

1 Next-Generation Biologics Market Overview

1.1 Product Overview and Scope of Next-Generation Biologics

1.2 Next-Generation Biologics Segment by Type

1.2.1 Global Next-Generation Biologics Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Antibodies

1.2.3 The Market Profile of Regenerative medicine

1.2.4 The Market Profile of Insulins

1.2.5 The Market Profile of Growth hormones

1.2.6 The Market Profile of Other

1.3 Global Next-Generation Biologics Segment by Application

1.3.1 Next-Generation Biologics Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Medical

1.3.3 The Market Profile of Scientific Research

1.3.4 The Market Profile of Other

1.4 Global Next-Generation Biologics Market by Region (2014-2026)

1.4.1 Global Next-Generation Biologics Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3 Europe Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.1 Germany Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.2 UK Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.3 France Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.4 Italy Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.5 Spain Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.6 Russia Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.3.7 Poland Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.4 China Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.5 Japan Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.6 India Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.8 Central and South America Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Next-Generation Biologics Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Next-Generation Biologics Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Next-Generation Biologics (2014-2026)

1.5.1 Global Next-Generation Biologics Revenue Status and Outlook (2014-2026)

1.5.2 Global Next-Generation Biologics Production Status and Outlook (2014-2026)

2 Global Next-Generation Biologics Market Landscape by Player

2.1 Global Next-Generation Biologics Production and Share by Player (2014-2019)

2.2 Global Next-Generation Biologics Revenue and Market Share by Player (2014-2019)

2.3 Global Next-Generation Biologics Average Price by Player (2014-2019)

2.4 Next-Generation Biologics Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Next-Generation Biologics Market Competitive Situation and Trends

2.5.1 Next-Generation Biologics Market Concentration Rate

2.5.2 Next-Generation Biologics Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 Sanofi

3.1.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Next-Generation Biologics Product Profiles, Application and Specification

3.1.3 Sanofi Next-Generation Biologics Market Performance (2014-2019)

3.1.4 Sanofi Business Overview

3.2 Eli Lilly

3.2.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Next-Generation Biologics Product Profiles, Application and Specification

3.2.3 Eli Lilly Next-Generation Biologics Market Performance (2014-2019)

3.2.4 Eli Lilly Business Overview

3.3 Kyowa Hakko Kirin

3.3.1 Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Next-Generation Biologics Product Profiles, Application and Specification

3.3.3 Kyowa Hakko Kirin Next-Generation Biologics Market Performance (2014-2019)

3.3.4 Kyowa Hakko Kirin Business Overview

3.4 Biogen Idec

3.4.1 Biogen Idec Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Next-Generation Biologics Product Profiles, Application and Specification

3.4.3 Biogen Idec Next-Generation Biologics Market Performance (2014-2019)

3.4.4 Biogen Idec Business Overview

3.5 Allergan

3.5.1 Allergan Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Next-Generation Biologics Product Profiles, Application and Specification

3.5.3 Allergan Next-Generation Biologics Market Performance (2014-2019)

3.5.4 Allergan Business Overview

3.6 Roche

3.6.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Next-Generation Biologics Product Profiles, Application and Specification

3.6.3 Roche Next-Generation Biologics Market Performance (2014-2019)

3.6.4 Roche Business Overview

3.7 Novo Nordisk

3.7.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Next-Generation Biologics Product Profiles, Application and Specification

3.7.3 Novo Nordisk Next-Generation Biologics Market Performance (2014-2019)

3.7.4 Novo Nordisk Business Overview

3.8 Bayer

3.8.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Next-Generation Biologics Product Profiles, Application and Specification

3.8.3 Bayer Next-Generation Biologics Market Performance (2014-2019)

3.8.4 Bayer Business Overview

3.9 Pfizer

3.9.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Next-Generation Biologics Product Profiles, Application and Specification

3.9.3 Pfizer Next-Generation Biologics Market Performance (2014-2019)

3.9.4 Pfizer Business Overview

3.10 Molecular Partners

3.10.1 Molecular Partners Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Next-Generation Biologics Product Profiles, Application and Specification

3.10.3 Molecular Partners Next-Generation Biologics Market Performance (2014-2019)

3.10.4 Molecular Partners Business Overview

4 Global Next-Generation Biologics Production, Revenue (Value), Price Trend by Type

4.1 Global Next-Generation Biologics Production and Market Share by Type (2014-2019)

4.2 Global Next-Generation Biologics Revenue and Market Share by Type (2014-2019)

4.3 Global Next-Generation Biologics Price by Type (2014-2019)

4.4 Global Next-Generation Biologics Production Growth Rate by Type (2014-2019)

4.4.1 Global Next-Generation Biologics Production Growth Rate of Antibodies (2014-2019)

4.4.2 Global Next-Generation Biologics Production Growth Rate of Regenerative medicine (2014-2019)

4.4.3 Global Next-Generation Biologics Production Growth Rate of Insulins (2014-2019)

4.4.4 Global Next-Generation Biologics Production Growth Rate of Growth hormones (2014-2019)

4.4.5 Global Next-Generation Biologics Production Growth Rate of Other (2014-2019)

5 Global Next-Generation Biologics Market Analysis by Application

5.1 Global Next-Generation Biologics Consumption and Market Share by Application (2014-2019)

5.2 Global Next-Generation Biologics Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Next-Generation Biologics Consumption Growth Rate of Medical (2014-2019)

5.2.2 Global Next-Generation Biologics Consumption Growth Rate of Scientific Research (2014-2019)

5.2.3 Global Next-Generation Biologics Consumption Growth Rate of Other (2014-2019)

6 Global Next-Generation Biologics Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Next-Generation Biologics Consumption by Region (2014-2019)

6.2 United States Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.3 Europe Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.4 China Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.5 Japan Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.6 India Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

7 Global Next-Generation Biologics Production, Revenue (Value) by Region (2014-2019)

7.1 Global Next-Generation Biologics Production and Market Share by Region (2014-2019)

7.2 Global Next-Generation Biologics Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

8 Next-Generation Biologics Manufacturing Analysis

8.1 Next-Generation Biologics Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Next-Generation Biologics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Next-Generation Biologics Industrial Chain Analysis

9.2 Raw Materials Sources of Next-Generation Biologics Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Next-Generation Biologics

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Next-Generation Biologics Market Forecast (2019-2026)

11.1 Global Next-Generation Biologics Production, Revenue Forecast (2019-2026)

11.1.1 Global Next-Generation Biologics Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Next-Generation Biologics Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Next-Generation Biologics Price and Trend Forecast (2019-2026)

11.2 Global Next-Generation Biologics Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Next-Generation Biologics Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Next-Generation Biologics Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source


List Of Figure

List of Tables and Figures

Figure Next-Generation Biologics Product Picture

Table Global Next-Generation Biologics Production and CAGR (%) Comparison by Type

Table Profile of Antibodies

Table Profile of Regenerative medicine

Table Profile of Insulins

Table Profile of Growth hormones

Table Profile of Other

Table Next-Generation Biologics Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Medical

Table Profile of Scientific Research

Table Profile of Other

Figure Global Next-Generation Biologics Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Europe Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Germany Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure UK Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure France Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Italy Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Spain Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Russia Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Poland Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure China Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Japan Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure India Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Malaysia Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Singapore Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Philippines Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Indonesia Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Thailand Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Vietnam Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Central and South America Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Brazil Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Mexico Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Colombia Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Turkey Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Egypt Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure South Africa Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Nigeria Next-Generation Biologics Revenue and Growth Rate (2014-2026)

Figure Global Next-Generation Biologics Production Status and Outlook (2014-2026)

Table Global Next-Generation Biologics Production by Player (2014-2019)

Table Global Next-Generation Biologics Production Share by Player (2014-2019)

Figure Global Next-Generation Biologics Production Share by Player in 2018

Table Next-Generation Biologics Revenue by Player (2014-2019)

Table Next-Generation Biologics Revenue Market Share by Player (2014-2019)

Table Next-Generation Biologics Price by Player (2014-2019)

Table Next-Generation Biologics Manufacturing Base Distribution and Sales Area by Player

Table Next-Generation Biologics Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table Sanofi Profile

Table Sanofi Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Eli Lilly Profile

Table Eli Lilly Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Kyowa Hakko Kirin Profile

Table Kyowa Hakko Kirin Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Biogen Idec Profile

Table Biogen Idec Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Allergan Profile

Table Allergan Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Roche Profile

Table Roche Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Novo Nordisk Profile

Table Novo Nordisk Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Bayer Profile

Table Bayer Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Pfizer Profile

Table Pfizer Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Molecular Partners Profile

Table Molecular Partners Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Next-Generation Biologics Production by Type (2014-2019)

Table Global Next-Generation Biologics Production Market Share by Type (2014-2019)

Figure Global Next-Generation Biologics Production Market Share by Type in 2018

Table Global Next-Generation Biologics Revenue by Type (2014-2019)

Table Global Next-Generation Biologics Revenue Market Share by Type (2014-2019)

Figure Global Next-Generation Biologics Revenue Market Share by Type in 2018

Table Next-Generation Biologics Price by Type (2014-2019)

Figure Global Next-Generation Biologics Production Growth Rate of Antibodies (2014-2019)

Figure Global Next-Generation Biologics Production Growth Rate of Regenerative medicine (2014-2019)

Figure Global Next-Generation Biologics Production Growth Rate of Insulins (2014-2019)

Figure Global Next-Generation Biologics Production Growth Rate of Growth hormones (2014-2019)

Figure Global Next-Generation Biologics Production Growth Rate of Other (2014-2019)

Table Global Next-Generation Biologics Consumption by Application (2014-2019)

Table Global Next-Generation Biologics Consumption Market Share by Application (2014-2019)

Table Global Next-Generation Biologics Consumption of Medical (2014-2019)

Table Global Next-Generation Biologics Consumption of Scientific Research (2014-2019)

Table Global Next-Generation Biologics Consumption of Other (2014-2019)

Table Global Next-Generation Biologics Consumption by Region (2014-2019)

Table Global Next-Generation Biologics Consumption Market Share by Region (2014-2019)

Table United States Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table Europe Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table China Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table Japan Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table India Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table Central and South America Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Next-Generation Biologics Production, Consumption, Export, Import (2014-2019)

Table Global Next-Generation Biologics Production by Region (2014-2019)

Table Global Next-Generation Biologics Production Market Share by Region (2014-2019)

Figure Global Next-Generation Biologics Production Market Share by Region (2014-2019)

Figure Global Next-Generation Biologics Production Market Share by Region in 2018

Table Global Next-Generation Biologics Revenue by Region (2014-2019)

Table Global Next-Generation Biologics Revenue Market Share by Region (2014-2019)

Figure Global Next-Generation Biologics Revenue Market Share by Region (2014-2019)

Figure Global Next-Generation Biologics Revenue Market Share by Region in 2018

Table Global Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table China Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table India Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Next-Generation Biologics Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Next-Generation Biologics

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Next-Generation Biologics

Figure Next-Generation Biologics Industrial Chain Analysis

Table Raw Materials Sources of Next-Generation Biologics Major Players in 2018

Table Downstream Buyers

Figure Global Next-Generation Biologics Production and Growth Rate Forecast (2019-2026)

Figure Global Next-Generation Biologics Revenue and Growth Rate Forecast (2019-2026)

Figure Global Next-Generation Biologics Price and Trend Forecast (2019-2026)

Table United States Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table Europe Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table China Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table Japan Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table India Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table Middle East and Africa Next-Generation Biologics Production, Consumption, Export and Import Forecast (2019-2026)

Table Global Next-Generation Biologics Market Production Forecast, by Type

Table Global Next-Generation Biologics Production Volume Market Share Forecast, by Type

Table Global Next-Generation Biologics Market Revenue Forecast, by Type

Table Global Next-Generation Biologics Revenue Market Share Forecast, by Type

Table Global Next-Generation Biologics Price Forecast, by Type

Table Global Next-Generation Biologics Market Production Forecast, by Application

Table Global Next-Generation Biologics Production Volume Market Share Forecast, by Application

Table Global Next-Generation Biologics Market Revenue Forecast, by Application

Table Global Next-Generation Biologics Revenue Market Share Forecast, by Application

Table Global Next-Generation Biologics Price Forecast, by Application

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS